Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsiveness

Ryan D. Gentzler, Alex C. Minella, Brady L. Stein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The classical myeloproliferative neoplasms (MPNs) feature an overproduction of mature blood elements. Phenotypic conversion, including transformation to myelofibrosis (MF) in those with antecedent ET and PV is a feared complication. Hypereosinophilic syndromes (HESs), especially those with myeloproliferative variants, can display similar features, including organomegaly, marrow fibrosis, clonality, thrombotic tendencies, and acute myeloid leukemia (AML) transformation. However, this group of illnesses is typically clinically and molecularly distinct from the classical MPNs. We report a case of a 59-yr-old woman with complex hypereosinophilia in the setting of post-polycythemic myelofibrosis (post-PVMF), with multi-system end-organ damage characteristic of HES.

Original languageEnglish (US)
Pages (from-to)9-12
Number of pages4
JournalLeukemia Research Reports
Volume1
Issue number1
DOIs
StatePublished - 2012

Keywords

  • Hypereosinophilia syndrome
  • Imatinib
  • Myelofibrosis
  • Myeloproliferative disorder
  • Polycythemia vera

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsiveness'. Together they form a unique fingerprint.

Cite this